Skip to main content
SYK
NYSE Industrial Applications And Services

Stryker Reports Strong Q4 & Full-Year 2025 Results, Provides Optimistic 2026 Outlook

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$360
Mkt Cap
$135.493B
52W Low
$329.161
52W High
$404.87
52W Position info
9.4% above low
Off High info
11% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

SYK is trading near its 52-week low of $329.161 (9.4% above the low).

Summary

Stryker Corporation announced robust fourth quarter and full-year 2025 operating results, featuring double-digit sales and adjusted EPS growth, alongside an optimistic outlook for 2026.


Key Events · Earnings and Guidance · SYK

  • Strong Q4 2025 Performance

    Reported net sales increased 11.4% to $7.2 billion, with organic net sales up 11.0%. Adjusted EPS grew 11.5% to $4.47.

  • Solid Full-Year 2025 Growth

    Full-year net sales reached $25.1 billion, an 11.2% increase, and adjusted EPS rose 11.8% to $13.63.

  • Operating Margin Expansion

    The company achieved a 100 basis point increase in adjusted operating income margin for both the fourth quarter (30.2%) and full year (26.3%).

  • Positive 2026 Outlook

    Stryker anticipates 2026 organic net sales growth between 8.0% and 9.5% and adjusted diluted EPS in the range of $14.90 to $15.10.


Analysis · SYK · Industrial Applications And Services

Stryker's latest earnings report signals strong operational momentum, exceeding $25 billion in annual revenue with consistent double-digit growth in both sales and adjusted earnings per share. The expansion of adjusted operating margins for the second consecutive year underscores effective cost management and operational efficiency. The positive 2026 outlook, projecting continued high-end MedTech growth, provides investors with clear forward guidance and reinforces confidence in the company's sustained performance. This robust financial health positions Stryker favorably within the competitive medical technology sector.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SYK was trading at $360.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $135.5B. The 52-week trading range was $329.16 to $404.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SYK - Latest Insights

SYK
Aug 31, 2026, 4:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $323.80
Real-time Price: $281.50 info
Change: -$42.30 (-13%) info
Market Cap: $107.976B info
SYK
Aug 17, 2026, 10:13 AM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $337.29
Real-time Price: $281.50 info
Change: -$55.79 (-17%) info
Market Cap: $107.976B info
SYK
Jul 31, 2026, 11:41 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $324.67
Real-time Price: $281.50 info
Change: -$43.17 (-13%) info
Market Cap: $107.976B info
SYK
Jul 30, 2026, 8:14 PM EDT
Source: Binance News
Importance Score:
7
Price at Filing: $321.06
Real-time Price: $281.50 info
Change: -$39.56 (-12%) info
Market Cap: $107.976B info
SYK
Jul 30, 2026, 4:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $316.00
Real-time Price: $281.50 info
Change: -$34.50 (-11%) info
Market Cap: $107.976B info